| MUSA |
Murphy USA Inc. |
Woodward Scott G. |
Officer
|
2026-02-06 |
M - A |
203 |
0.00 |
0.00 |
203 |
| MUSA |
Murphy USA Inc. |
Woodward Scott G. |
Officer
|
2026-02-06 |
F - D |
99 |
397.42 |
39,344.58 |
104 |
| MUSA |
Murphy USA Inc. |
Woodward Scott G. |
Officer
|
2026-02-06 |
M - D |
203 |
0.00 |
0.00 |
302 |
| GGG |
GRACO INC |
Wordell Angela F |
Officer
|
2026-02-06 |
M - A |
2,832 |
30.35 |
85,941.85 |
16,192 |
| GGG |
GRACO INC |
Wordell Angela F |
Officer
|
2026-02-06 |
S - D |
2,832 |
93.22 |
263,993.09 |
13,360 |
| GGG |
GRACO INC |
Wordell Angela F |
Officer
|
2026-02-06 |
M - D |
2,832 |
0.00 |
0.00 |
0 |
| RAL |
Ralliant Corp |
Worrell Brian |
Director
|
2026-02-06 |
P - A |
2,500 |
39.93 |
99,825.00 |
5,904 |
| PEBO |
PEOPLES BANCORP INC |
Wyatt Douglas Vincent |
Officer
|
2026-02-06 |
F - D |
1,263 |
34.18 |
43,169.34 |
24,504 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - A |
1,151,540 |
0.00 |
0.00 |
1,290,428 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - A |
2,155,765 |
0.00 |
0.00 |
2,294,653 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
10,000,000 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
7,807,026 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
2,502,252 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
796,380 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
530,920 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
5,289,322 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
3,526,215 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
303,360 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
1,450,614 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
10,266,152 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Wolfe Josh |
|
2026-02-06 |
C - A |
2,387,705 |
0.00 |
0.00 |
2,387,705 |
| EIKN |
Eikon Therapeutics, Inc. |
Wolfe Josh |
|
2026-02-06 |
C - A |
1,151,540 |
0.00 |
0.00 |
1,290,428 |
| EIKN |
Eikon Therapeutics, Inc. |
Wolfe Josh |
|
2026-02-06 |
C - A |
2,155,765 |
0.00 |
0.00 |
2,294,653 |
| EIKN |
Eikon Therapeutics, Inc. |
Wolfe Josh |
|
2026-02-06 |
C - D |
10,000,000 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Wolfe Josh |
|
2026-02-06 |
C - D |
7,807,026 |
0.00 |
0.00 |
0 |